COO William Todd Zehnder Increases Stake in Viemed Healthcare Following Option Exercise
VMD sits 35% above its 52-week low of $5.93 on elevated volume (2.0× avg).
Summary
Viemed Healthcare's COO and Director, William Todd Zehnder, increased his direct ownership by a net of 15,474 shares through option exercises, demonstrating continued confidence in the company.
Key Events · Ownership and Investor Activity · VMD
-
COO Increases Direct Ownership
William Todd Zehnder, COO and Director, acquired 35,790 shares through option exercises, leading to a net increase of 15,474 shares in his direct holdings after accounting for tax-related dispositions.
-
Significant Insider Investment
The option exercise represents a total buy value of $286,320, indicating a substantial personal investment by a key executive.
-
Follows Recent Insider Activity
This transaction follows a previous significant increase in ownership by the COO on January 23, 2026, and by the CEO on the same date, signaling a pattern of strong insider confidence.
-
Stock Trading Near 52-Week High
The insider activity occurs while Viemed Healthcare's stock is trading near its 52-week high, potentially reflecting the COO's belief in continued growth.
Analysis · VMD · Industrial Applications And Services
Chief Operating Officer William Todd Zehnder exercised options to acquire 35,790 shares, partially offset by dispositions for tax withholding and to the issuer, resulting in a net increase of 15,474 shares in his direct holdings. This transaction, with a total buy value of $286,320, represents a notable increase in insider ownership by a key executive. The activity occurs while the stock is trading near its 52-week high, suggesting the COO sees further upside potential. This follows a previous significant increase in ownership by the COO on January 23, 2026, reinforcing a pattern of insider confidence.
At the time of this filing, VMD was trading at $8.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $304.1M. The 52-week trading range was $5.93 to $8.42. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.